Proteus: mad cows to the rescue
Article Abstract:
Enfer Scientific has had a postmortem test for mad cow disease validated by the research wing of the Irish Department of Agriculture. The test uses technology from Proteus, which has seen a rise in its share price following the announcement. Proteus has made an agreement with Enfer which has global rights to the test and Proteus will receive a 12.5% share on each test's value. There could still be regulatory difficulties, and mad cow disease is declining in Europe.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Dechra reigns cats and dogs
Article Abstract:
Dechra Pharmaceuticals is a pet medicine, vet supplies and pet accessory company which is performing well as a strong player in a fragmented market. The company plans a stock flotation in Sep 2000.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Dechra Pharmaceuticals
Article Abstract:
Dechra Pharmaceuticals has a strong position in the British market for distributors to vets of pharmaceutical products, though this market could be affected by an economic downturn.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Promotion helps reader catch the bug, increases brand awareness. Successful mortgage contest drives circulation, helps brand
- Abstracts: A spec ad how-to. The insanity of telemarketing. Selling more, making more
- Abstracts: Crusade against the coronary. Climatotherapy. Tried and tested
- Abstracts: Recruiting and retaining. Benching the benchmark. Who needs a triple A?
- Abstracts: The American way. Fast track to success. The secret of their success